Top Markets
#1 Akedo Akedo +73.71%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.71%
#4 Cross Cross +43.52%
#5 Black Phoenix Black Phoenix +33.78%
#6 Cap Cap +25.61%
#7 Velvet Velvet +25.32%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.62%
#9 DoubleZero DoubleZero +12.53%
#10 Humanity Humanity +10.30%
Coin of the day
Akedo Akedo
설정
언어
한국어
통화
USD
테마
Captor Capital Corp. Captor Capital Corp.

Captor Capital Corp.

CPTR
주식 순위 #39299
Captor Capital Corp., headquartered in Toronto, Canada, was founded in 2003 and... Captor Capital Corp., headquartered in Toronto, Canada, was founded in 2003 and engages in the production and retail distribution of cannabis products across the United States. The company, which rebranded from NWT Uranium Corp. on June 2, 2017, operates a network of nine dispensaries under its "One Plant" brand within California. These retail locations include Santa Cruz, Antioch, El Sobrante, Salinas, Lompoc, Goleta, Atwater, Palm Springs, and Castroville. Complementing its physical stores, Captor Capital Corp. also manages an online retail portal, also under the "One Plant" banner.
주가
$0.16146612
마지막 동기화: 2026-06-18
시가총액
$563.02K
변동 (1일)
0.00%
변동 (1년)
-54.48%
국가
CA
거래 Captor Capital Corp. (CPTR)

카테고리

Healthcare
Captor Capital Corp. (CPTR)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Captor Capital Corp.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Captor Capital Corp.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
8.17 -
IN